FAK is also linked to the higher pathological stage, metastasis, and shorter overall survival rate, as well as drug resistance to platinum‐ and taxane‐based chemotherapy of ovarian cancer patients.27, 28. The gene discussed is PTK2; the disease is ovarian carcinoma.